Exogenous endophthalmitis is a devastating complication of any intraocular procedure that can occur despite the most stringent antiseptic techniques. Fortunately, the rates of endophthalmitis after intraocular procedures are low and have declined steadily over the last 20 years.1 Unfortunately, visual outcomes are highly variable and often additional complications develop, including retinal detachments, macular edema, and hypotony, among others.2 Clinical decision-making in endophthalmitis cases has been guided largely by the Endophthalmitis Vitrectomy Study (EVS) published in 1995.
